MYC and cancer: Several oncogenic proteins and tumor suppressors, including the hypoxia-inducible factor (HIF-1), Myc, p53, and PI3K/Akt/mTOR pathway, have been implicated in regulating this cancer cell-specific metabolic reprogramming.